Healthcare / Medical - Healthcare Information ServicesUpdated 2026-05-10 22:07 UTC

ETR/VEE stock hub

ETR/VEE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/VEEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.1B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/VEE

In the news

Latest news · ETR/VEE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.3

P25 12.3P50 15.7P75 20.2

Trailing P/E30.2

P25 16.4P50 20.9P75 30.4

ROE13.9

P25 -6.7P50 8.5P75 17.2

ROIC115.9

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/VEE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	7,928
Employees Change	637%
Employees Change Percent	8.74
Enterprise value	EUR 17.6B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Healthcare Information Services
Isin	US9224751084
Last refreshed	2026-05-10
Market cap	EUR 23.1B
Price	EUR 140
Price currency	EUR
Rev Per Employee	339,239.82x
Sector	Healthcare
Sic	7370
Symbol	etr/VEE
Website	https://www.veeva.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.31%
EV Earnings	22.99x
EV/EBIT	21.86x
EV/EBITDA	20.66x
EV/FCF	15.08x
EV/Sales	6.48x
FCF yield	5.05%
Forward P/E	18.34x
P/B ratio	3.8x
P/E ratio	30.17x
P/S ratio	8.58x
PE Ratio10 Y	73.61x
PE Ratio3 Y	53.28x
PE Ratio5 Y	66.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	29.64%
EBITDA Margin	30.83%
FCF margin	43.38%
Gross margin	75.53%
Gross Profit	EUR 2B
Gross Profit Growth	17.9%
Gross Profit Growth Q	15.3%
Gross Profit Growth3 Y	16.01%
Gross Profit Growth5 Y	17.97%
Net Income	EUR 765M
Net Income Growth	27.27%
Net Income Growth Q	24.83%
Net Income Growth Quarters	8%
Net Income Growth Years	15%
Net Income Growth3 Y	23.06%
Net Income Growth5 Y	19.05%
Pretax Margin	37.38%
Profit Margin	28.44%
Profit Per Employee	EUR 96,497
Profitable Years	16
ROA	7.25
Roa5y	6.94
ROCE	12.9
ROE	13.93
Roe5y	14.27
ROIC	115.9
Roic5y	72.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-24.77%
Cagr3y	-5.23%
Cagr5y	-8.35%
EPS Growth	25.93
EPS Growth Q	23.16
EPS Growth Quarters	8
EPS Growth Years	12
EPS Growth3 Y	21.94
EPS Growth5 Y	18.18
FCF Growth	29.6%
FCF Growth Q	53.98%
FCF Growth3 Y	21.81%
FCF Growth5 Y	20.63%
OCF Growth	29.83%
OCF Growth Q	53.64%
OCF Growth10 Y	33.26%
OCF Growth3 Y	21.94%
OCF Growth5 Y	20.75%
Revenue Growth	16.34x
Revenue Growth Q	15.96x
Revenue Growth Quarters	50x
Revenue Growth Years	15x
Revenue Growth3 Y	14.03x
Revenue Growth5 Y	16.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.39
Assets	EUR 7.6B
Cash	EUR 5.5B
Current Assets	EUR 6.8B
Current Liabilities	EUR 1.4B
Debt	EUR 80.7M
Debt EBITDA	EUR 0.1
Debt Equity	EUR 0.01
Debt FCF	EUR 0.07
Equity	EUR 6.1B
Liabilities	EUR 1.5B
Long Term Assets	EUR 776.2M
Long Term Liabilities	EUR 97.1M
Net Cash	EUR 5.4B
Net Cash By Market Cap	EUR 23.57
Net Cash Growth	27.4%
Net Debt EBITDA	EUR -6.56
Net Debt Equity	EUR -0.9
Net Debt FCF	EUR -4.66
Tangible Book Value	EUR 5.7B
Tangible Book Value Per Share	EUR 34.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.89
Net Working Capital	EUR -158.3M
Quick ratio	4.81
Working Capital	EUR 5.4B
Working Capital Turnover	EUR 0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-24.76%
200-day SMA	196.5
3Y total return	-14.88%
50-day SMA	149.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-35.32%
All Time High	289.4
All Time High Change	-51.59%
All Time High Date	2021-08-06
All Time Low	128.3
All Time Low Change	9.24%
All Time Low Date	2026-04-13
ATR	4.7
Ch YTD	-27.07
High	144.3
High52	263.8
High52 Date	2025-10-08
High52ch	-46.89%
Low	140
Low52	128.3
Low52 Date	2026-04-13
Low52ch	9.24%
Ma50ch	-6.47%
Price vs 200-day SMA	-28.69%
RSI	46.36
RSI Monthly	39.72
RSI Weekly	36.92
Sharpe ratio	-0.83x
Sortino ratio	-1.18
Total Return	-1.07%
Tr YTD	-27.07
Tr1m	-5.31%
Tr1w	-4.69%
Tr3m	-9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 797.1M
Operating Income Growth	35.98
Operating Income Growth Q	30.49
Operating Income Growth3 Y	27.3
Operating Income Growth5 Y	20.18
Operating margin	29.64

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	149,857,499%
Shares Insiders	8.21%
Shares Institutions	88.05%
Shares Qo Q	-0.4%
Shares Yo Y	1.07%
Short Ratio	1.99

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 768.8M
Average Volume	423.55x
Bv Per Share	37.08
CAPEX	EUR -24.5M
Ch1m	-5.31
Ch1w	-4.69
Ch1y	-24.76
Ch3m	-9
Ch3y	-14.88
Ch5y	-35.32
Ch6m	-44
Change	-4.89%
Change From Open	-2.37
Close	147.3
Days Gap	-2.58
Depreciation Amortization	32,198,813.1
Dollar Volume	122,447.4
Earnings Date	2026-05-27
EBIT	EUR 797.1M
EBITDA	EUR 829M
EPS	EUR 4.58
F Score	6
FCF	EUR 1.2B
FCF EV Yield	6.63x
Financing CF	-7,855,586
Fiscal Year End	January
Founded	2,007
Goodwill	372,998,980.7
Graham Number	62.05507
Graham Upside	-55.71
Income Tax	EUR 240.4M
Investing CF	-929,541,495
Is Primary Listing	0
Last Earnings Date	2026-03-04
Last Report Date	2026-01-31
Lynch Fair Value	EUR 88.48
Lynch Upside	-36.85
Ma150	190
Ma150ch	-26.25%
Ma20	139.3
Ma20ch	0.56%
Net CF	254,571,323
Next Earnings Date	2026-05-27
Open	143.5
P FCF Ratio	19.78
P OCF Ratio	19.38
Position In Range	2.35
Ppne	123,706,632.3
Price Date	2026-05-08
Price EBITDA	EUR 27.84
Ptbv Ratio	4.07
Relative Volume	2.06x
Revenue	2,689,493,269x
SBC By Revenue	14.79x
Share Based Comp	397,874,115
Tax By Revenue	8.94x
Tax Rate	23.91%
Tr6m	-44%
Volume	874
Z Score	16.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/VEE pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/VEE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/VEE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.1%

Share of float held by funds and institutions

Insider ownership

+8.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/VEE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.4

Neutral momentum band

Price vs 200-day MA

-28.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/VEE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/VEE stock rating?

etr/VEE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/VEE analysis?

The full report lives at /stocks/etr/VEE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/VEE?

The latest report frames etr/VEE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/VEE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.